{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:10:07Z","timestamp":1790071807128,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ygyno.2023.07.013","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T15:21:44Z","timestamp":1691508104000},"page":"173-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Vulvar cancer survival by primary treatment modality: A retrospective cohort study"],"prefix":"10.1016","volume":"176","author":[{"given":"Kelly H.","family":"Bruce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Alabaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur-Quan M.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2023.07.013_bb0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"10 Suppl","key":"10.1016\/j.ygyno.2023.07.013_bb0010","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/cncr.23759","article-title":"Incidence of in situ and invasive vulvar cancer in the US, 1998-2003","volume":"113","author":"Saraiya","year":"2008","journal-title":"Cancer."},{"issue":"3","key":"10.1016\/j.ygyno.2023.07.013_bb0015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.AOG.0000202404.55215.72","article-title":"Carcinoma of the vulva","volume":"107","author":"Stehman","year":"2006","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.07.013_bb0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.hoc.2011.10.006","article-title":"Current management of vulvar cancer","volume":"26","author":"Fuh","year":"2012","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"31","key":"10.1016\/j.ygyno.2023.07.013_bb0025","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1200\/JCO.2011.41.2528","article-title":"Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study","volume":"30","author":"Levenback","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.07.013_bb0030","first-page":"CD003752","article-title":"Neoadjuvant chemoradiation for advanced primary vulvar cancer","volume":"3","author":"van Doorn","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.ygyno.2023.07.013_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(98)00193-X","article-title":"Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the gynecologic oncology group","volume":"42","author":"Moore","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.ygyno.2023.07.013_bb0040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2011.11.003","article-title":"A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study","volume":"124","author":"Moore","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.07.013_bb0045","series-title":"Presented at the Society of Gynecologic Oncology Annual Meeting on Women\u2019s Cancer, Tampa, FL","article-title":"A phase II trial evaluating cisplatin and gemcitabine concurrent with intensity-modulated radiation therapy (IMRT) in the treatment of locally advanced squamous cell carcinoma of the vulva: An NRG oncology group study","author":"Horowitz","year":"2023"},{"issue":"4","key":"10.1016\/j.ygyno.2023.07.013_bb0055","first-page":"CD003752","article-title":"Chemoradiation for advanced primary vulval cancer","author":"Shylasree","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.ygyno.2023.07.013_bb0060","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ygyno.2007.11.010","article-title":"Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation","volume":"108","author":"Landrum","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2023.07.013_bb0065","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/IGC.0000000000000811","article-title":"Definitive Chemoradiotherapy for vulvar Cancer","volume":"26","author":"Natesan","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2023.07.013_bb0070","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/IGC.0000000000000938","article-title":"Primary versus preoperative radiation for locally advanced vulvar Cancer","volume":"27","author":"Natesan","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2023.07.013_bb0075","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2018.01.007","article-title":"Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy","volume":"148","author":"Stecklein","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.07.013_bb0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ygyno.2019.11.027","article-title":"High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: outcome and toxicity","volume":"156","author":"Rishi","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"9077","key":"10.1016\/j.ygyno.2023.07.013_bb0085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","article-title":"Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer","volume":"350","author":"Landoni","year":"1997","journal-title":"Lancet."},{"key":"10.1016\/j.ygyno.2023.07.013_bb0090","series-title":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Vulvar Cancer (Squamous Cell Carcinoma). NCCN.org","author":"NCCN","year":"2021"},{"key":"10.1016\/j.ygyno.2023.07.013_bb0095","author":"Karam"},{"issue":"2","key":"10.1016\/j.ygyno.2023.07.013_bb0100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00432-015-2060-9","article-title":"Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins","volume":"142","author":"Ignatov","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.07.013_bb0105","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ygyno.2013.05.036","article-title":"Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma","volume":"130","author":"Viswanathan","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.07.013_bb0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ygyno.2018.08.002","article-title":"Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapy","volume":"151","author":"Horne","year":"2018","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823014142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823014142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:04:35Z","timestamp":1758773075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823014142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":21,"alternative-id":["S0090825823014142"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.07.013","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vulvar cancer survival by primary treatment modality: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}